share_log

Cantor Fitzgerald Reiterates Overweight on Pfizer, Maintains $45 Price Target

Benzinga ·  Sep 16 12:25  · Ratings

Cantor Fitzgerald analyst Louise Chen reiterates Pfizer (NYSE:PFE) with a Overweight and maintains $45 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment